Search Results
DCGI approves phase 2, 3 trials of ‘Covaxin’ on 2 to 18 year-olds
Coronavirus Vaccine News | DCGI Approves Phase 2 And 3 Trials Of Covaxin Of 2-18 Year-Old
Bharat Biotech’s 'Covaxin' gets DCGI nod for phase 2, 3 clinical trials on children aged 2 to 18 yrs
Covaxin clinical trials for children (2 – 18 years) approved by DCGI
Covid-19 Vaccine For Kids | Covaxin Gets Approval For Phase 2-3 Clinical Trials For 2-18 Age Group
DCGI Approves Covaxin Clinical Trial On 2-18 Year Age Group | OTV News
DCGI Approves Phase II, III Clinical Trials Of COVAXIN For The Age Group Of 2 To 18 Years
Corona Crisis: DCGI approves phase II & III trial of Covaxin for kids
Covaxin for kids: Bharat Biotech completes phase 2/3 trials, to submit data to DCGI next week
Covaxin Approved By Expert Panel For Phase 2/3 Trials On 2-18 Year-Olds: Sources
DCGI allows Phase II-III clinical trial of Covaxin on 2 to 18-years-old
Expert Panel Approves Covaxin Phase 2& 3 Trials For Children Between 2-18 Years